Grace Therapeutics, Inc. (GRCE)

Grace Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	11.06	23.01	27.88	30.34	50.94	14.24
Short-Term Investments	-	-	0.02	13.32	9.79	-
Cash & Short-Term Investments	11.06	23.01	27.89	43.66	60.73	14.24
Cash Growth	-55.98%	-17.52%	-36.12%	-28.11%	326.48%	-44.72%
Other Receivables	0.3	0.72	0.8	0.55	0.53	0.55
Receivables	0.3	0.72	0.8	0.55	0.53	0.55
Prepaid Expenses	0.58	0.28	0.6	0.72	0.34	0.98
Other Current Assets	-	-	-	0.35	0.77	2.7
Total Current Assets	11.94	24.01	29.29	45.28	62.37	18.46
Property, Plant & Equipment	0.02	0.01	0.57	0.57	0.09	0.15
Goodwill	8.14	8.14	8.14	12.96	-	-
Other Intangible Assets	41.13	41.15	41.13	69.81	-	4.24
Total Assets	61.22	73.3	79.12	128.62	62.46	22.85
Accounts Payable	0.67	1.01	1.24	1.68	0.12	1.71
Accrued Expenses	1.31	0.68	2.09	1.48	1.38	5.61
Current Portion of Leases	-	-	0.08	0.1	0.09	0.08
Total Current Liabilities	1.97	1.68	3.41	3.26	1.58	7.4
Long-Term Leases	-	-	0.41	0.19	-	0.07
Long-Term Deferred Tax Liabilities	3.33	5.51	7.35	16.89	-	-
Other Long-Term Liabilities	3.78	4.36	-	0.01	5.22	2.39
Total Liabilities	9.09	11.56	11.17	20.35	6.8	9.86
Common Stock	0	261.04	258.29	257.99	197.19	137.42
Additional Paid-In Capital	279.5	17.86	13.97	12.15	10.82	9.8
Retained Earnings	-221.32	-211.12	-198.27	-155.84	-146.02	-126.34
Comprehensive Income & Other	-6.04	-6.04	-6.04	-6.04	-6.33	-7.89
Shareholders' Equity	52.14	61.74	67.96	108.27	55.66	12.99
Total Liabilities & Equity	61.22	73.3	79.12	128.62	62.46	22.85
Total Debt	-	-	0.49	0.3	0.09	0.15
Net Cash (Debt)	11.06	23.01	27.41	43.37	60.65	14.09
Net Cash Growth	-55.94%	-16.05%	-36.80%	-28.49%	330.32%	-42.28%
Net Cash Per Share	0.96	2.41	3.69	7.06	24.54	8.00
Filing Date Shares Outstanding	10.14	9.4	7.44	7.38	4.34	1.93
Total Common Shares Outstanding	10.14	9.4	7.44	7.38	4.34	1.88
Working Capital	9.97	22.33	25.88	42.02	60.79	11.07
Book Value Per Share	5.14	6.57	9.14	14.67	12.82	6.91
Tangible Book Value	2.87	12.46	18.69	25.5	55.66	8.75
Tangible Book Value Per Share	0.28	1.33	2.51	3.45	12.82	4.66
Machinery	-	0.61	0.67	0.7	-	-

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q